Urinary Tract Cancer

10 clinical trials · Condition

Record	Firm	Date
Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC). (NCT05038657)	University Hospital Southampton NHS Foundation Trust	2022-05-30
Multimodal Spectroscopy to Detect Urothelial Cancer in Urine (NCT04718948)	University of Florence	2021-01-28
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S (NCT04430842)	Quadriga Biosciences, Inc.	2020-07-20
A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract (NCT02928406)	Hoffmann-La Roche	2016-11-30
CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma (NCT03013920)	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	2016-08-01
A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer (NCT02006667)	Hoffmann-La Roche	2001-01-01
A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer (NCT02013765)	Hoffmann-La Roche	2001-01-01
Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study (NCT03410641)	Oslo University Hospital	1972-01-15

Every clearance here is in the API, with alerts when new ones post.